KOS vs REGN · rev $1.68B vs P/E 14, rev $14.34B
Kosmos Energy Ltd (KOS) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Kosmos Energy Ltd (KOS) is a oil & gas e&p company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported KOS revenue for 2024-12-31 was $1.68B. Net income was $189.9M. Revenue was down 2.5% from 2023-12-31 to 2024-12-31. KOS currently screens at market cap $1.02B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
KOS currently screens at market cap $1.02B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the KOS and REGN stock pages for the full models.
Not investment advice.